Endophilin A2 Deficiency Impairs Antibody Production in Humans.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE
    • Publication Information:
      Publication: Amsterdam : Springer
      Original Publication: New York : Plenum, c1981-
    • Subject Terms:
    • Abstract:
      Endophilin A2, the sole endophilin A family member expressed in hematopoietic cells, regulates various aspects of membrane dynamics, including autophagy and endocytosis. Recent studies in rodents highlight the essential role of endophilin A2 in modulating immune responses. Here we report a homozygous frameshift variant in the SH3GL1 gene (NM_003025.3:c.427delC; p.Leu143Serfs*9), detected by whole exome sequencing in a 14-year-old boy with predominantly antibody deficiency. The patient who is issued from a consanguineous Lebanese family, presents since the age of 18 months with recurrent respiratory tract infections, low peripheral B cell counts and pan-hypogammaglobulinemia, with no history of opportunistic infections. This defect is associated with decrease in switched memory B cells development, impaired in-vitro B cell proliferation and diminished in-vitro IgG production. The detected variant in SH3GL1 segregates with the disease in the family. It significantly decreases the expression of the protein in the patient's peripheral blood compared to healthy controls, thus confirming its pathogenicity. Interestingly, endophilin A2-deficient Sh3gl1 -/- mice have been reported to present defects in germinal center B cell responses and in the production of high-affinity IgG. Our data suggests that endophilin A2 deficiency impairs antibody production in humans. Reporting further cases with mutations in SH3GL1 is needed to better characterize the inborn error of immunity linked to this gene.
      (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
    • References:
      Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS Phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508–20. (PMID: 10.1007/s10875-022-01352-z36198931)
      Fried AJ, Bonilla FA. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev. 2009;22:396–414. (PMID: 10.1128/CMR.00001-09195970062708392)
      Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227. (PMID: 10.1146/annurev.immunol.021908.13264919302039)
      Amirifar P, Yazdani R, Azizi G, Ranjouri MR, Durandy A, Plebani A et al. F Candotti editor 2021 Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies. Pediatr Allergy Immunol 32 1601–15. (PMID: 10.1111/pai.1358934181780)
      Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, et al. The Middle East and North Africa Diagnosis and management guidelines for inborn errors of immunity. J Allergy Clin Immunol Pract. 2023;11:158–e18011. (PMID: 10.1016/j.jaip.2022.10.00336265766)
      Durandy A, Kracker S, Fischer A. Primary antibody deficiencies. Nat Rev Immunol. 2013;13:519–33. (PMID: 10.1038/nri346623765059)
      Kroll J, Jaime Tobón LM, Vogl C, Neef J, Kondratiuk I, König M, et al. Endophilin-A regulates presynaptic ca 2+ influx and synaptic vesicle recycling in auditory hair cells. EMBO J. 2019;38:e100116. (PMID: 10.15252/embj.2018100116307332436396150)
      Malinova D, Wasim L, Newman R, Martínez-Riaño A, Engels N, Tolar P. Endophilin A2 regulates B‐cell endocytosis and is required for germinal center and humoral responses. EMBO Rep. 2021;22:e51328. (PMID: 10.15252/embr.202051328343233518419706)
      Gortat A, San-Roman MJ, Vannier C, Schmidt AA. Single point mutation in Bin/Amphiphysin/Rvs (BAR) sequence of Endophilin impairs dimerization, membrane shaping, and Src Homology 3 domain-mediated Partnership. J Biol Chem. 2012;287:4232–47. (PMID: 10.1074/jbc.M111.32583722167186)
      Liu C, zhao, Li F, ya, Lv X, fei, Ma M ming, Li X, yu, Lin C et al. xia,. Endophilin A2 regulates calcium-activated chloride channel activity via selective autophagy-mediated TMEM16A degradation. Acta Pharmacol Sin. 2020;41:208–17.
      Boucrot E, Ferreira APA, Almeida-Souza L, Debard S, Vallis Y, Howard G, et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature. 2015;517:460–5. (PMID: 10.1038/nature1406725517094)
      Milosevic I, Giovedi S, Lou X, Raimondi A, Collesi C, Shen H, et al. Recruitment of Endophilin to clathrin-coated pit necks is required for efficient vesicle uncoating after Fission. Neuron. 2011;72:587–601. (PMID: 10.1016/j.neuron.2011.08.029220994613258500)
      Xie MX, Lai RC, Xiao YB, Zhang X, Cao XY, Tian XY, et al. Endophilin A2 controls touch and mechanical allodynia via kinesin-mediated Piezo2 trafficking. Military Med Res. 2024;11:17. (PMID: 10.1186/s40779-024-00520-z)
      Baldassarre T, Truesdell P, Craig AW. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers. Breast Cancer Res. 2017;19:110. (PMID: 10.1186/s13058-017-0900-z289742665627411)
      Baldassarre T, Watt K, Truesdell P, Meens J, Schneider MM, Sengupta SK, et al. Endophilin A2 promotes TNBC Cell Invasion and Tumor Metastasis. Mol Cancer Res. 2015;13:1044–55. (PMID: 10.1158/1541-7786.MCR-14-057325784716)
      Norin U, Rintisch C, Meng L, Forster F, Ekman D, Tuncel J, et al. Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation. Nat Commun. 2021;12:610. (PMID: 10.1038/s41467-020-20586-2335047857840939)
      Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, et al. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics. 2009;25:2744–50. (PMID: 10.1093/bioinformatics/btp528197341543140805)
      McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303. (PMID: 10.1101/gr.107524.110206441992928508)
      Desvignes JP, Bartoli M, Delague V, Krahn M, Miltgen M, Béroud C, et al. VarAFT: a variant annotation and filtration system for human next generation sequencing data. Nucleic Acids Res. 2018;46:W545–53. (PMID: 10.1093/nar/gky471298604846030844)
      Vázquez-Fonseca L, Schäefer J, Navas-Enamorado I, Santos-Ocaña C, Hernández-Camacho JD, Guerra I, et al. ADCK2 haploinsufficiency reduces mitochondrial lipid oxidation and causes Myopathy Associated with CoQ Deficiency. JCM. 2019;8:1374. (PMID: 10.3390/jcm8091374314808086780728)
      Lagier-Tourenne C, Tazir M, López LC, Quinzii CM, Assoum M, Drouot N, et al. ADCK3, an ancestral kinase, is mutated in a form of recessive Ataxia Associated with Coenzyme Q10 Deficiency. Am J Hum Genet. 2008;82:661–72. (PMID: 10.1016/j.ajhg.2007.12.024183190742427193)
      Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013;123:5179–89. (PMID: 10.1172/JCI69000242704203859425)
      Yang LQ, Huang AF, Xu WD. Biology of endophilin and it’s role in disease. Front Immunol. 2023;14:1297506. (PMID: 10.3389/fimmu.2023.12975063811601210728279)
      McShane AN, Malinova D. The Ins and outs of Antigen Uptake in B cells. Front Immunol. 2022;13:892169. (PMID: 10.3389/fimmu.2022.892169355725449097226)
    • Contributed Indexing:
      Keywords: Endophilin A2; Exome sequencing; Predominantly antibody deficiency; SH3GL1
    • Accession Number:
      EC 2.3.- (Acyltransferases)
      EC 2.3.1.52 (2-acylglycerophosphate acyltransferase)
      0 (Immunoglobulin G)
    • Publication Date:
      Date Created: 20241105 Date Completed: 20241105 Latest Revision: 20241205
    • Publication Date:
      20241209
    • Accession Number:
      10.1007/s10875-024-01827-1
    • Accession Number:
      39499372